Navigation Links
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Date:6/4/2008

eloping its own therapeutic pipeline in the field of neurodegenerative diseases and cancer. The Company has advanced drug candidates into clinical trials and is evaluating several promising pre-clinical compounds. ExonHit also has a strategic partnership with Allergan, to discover and develop new therapeutics in the areas of pain, neurological diseases and ophthalmology. This collaboration provides on-going research funding to ExonHit.

Founded in 1997, ExonHit is headquartered in Paris, France and has a U.S. facility in Gaithersburg, Maryland. The Company is listed on Alternext of Euronext Paris (ticker: ALEHT; ISIN: FR0004054427) since November 17, 2005.

This press release includes only summary information and does not purport to be comprehensive. The projections, forecast and estimates of ExonHit Therapeutics which may be contained herein are for illustrative purposes only and are based on management's current views and assumptions. Such projections, forecast and estimates involve known and unknown risks and uncertainties, as described at Section 4.2 "Facteurs de risque" (Risk Factors) of the Document de Base available on ExonHit Therapeutics' website (http://www.exonhit.com), that may cause actual results, performance or events to differ materially from those anticipated in the summary information.

In addition, ExonHit Therapeutics, its shareholders, and its affiliates, directors, officers, advisors and employees have not verified the accuracy of, and make no representations or warranties in relation to, statistical data or predictions contained in this press release that were taken or derived from third party sources or industry publications, and such statistical data and predictions are used in this press release for information purposes only.

Finally, this press release may be drafted in the French and English languages. In an event of differences between the texts, the French langu
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. David M. Stout Joins NanoBio Corporations Board of Directors
2. Dan Renick, RPh, Joins The Hobart Group as Managing Partner
3. Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
4. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
5. Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
6. Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
7. Basil Zimmo Joins Finesse Solutions as Vice-President of Software
8. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
9. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
10. Harvey Morgan Joins CryoLife Board of Directors
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Tauriga Sciences, Inc. (OTCQB:  TAUG) ("Tauriga" or ... interests in the natural wellness sector and in ... announced that it has officially extinguished all further ... for a one-time cash payment of $230,000 USD.  ... entered into a Settlement Agreement (the "Settlement Agreement") ...
(Date:6/2/2015)... 2015 Meet ARGUS, The World,s ... & Read People. Analyze emotions and predict actions. Explore ... the very first Responsive-RPG: "The Eye: Genesis". ... , , , https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 ... your inner feelings - and those of others. Being ...
(Date:6/2/2015)... 2015   Hospira, Inc. (NYSE: HSP ... its partner, Celltrion – a global biopharmaceutical company – has ... Agency in Brazil – for ... use in Brazil . The medication ... sells biosimilar infliximab in 26 European countries and in ...
(Date:6/2/2015)... , June 2, 2015   BioClinica ® , ... provider, today announced that David Peters , an ... Executive Vice President and Chief Financial Officer (CFO) and ... Peters brings more than 25 years of financial ... "David has extensive and deep knowledge in all areas ...
Breaking Biology Technology:Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 3Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 4ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5BioClinica Names David Peters New Chief Financial Officer 2
... space agency announced this month it wants to return to the ... longer trip to Mars . Others say the National ... lifeless satellite and head directly for the red planet, where there ... get out of the business of space flight and let private ...
... second-rate solution for something as critical as its network infrastructure. ... other product and service arena. , ,Speed is the common ... general metric for assessing whether or not a product is ... , ,To paraphrase Gordon Gekko's Greed is Good ...
... products do not infringe on patents held by a ... dismiss a lawsuit brought against the Mountain View, Calif. firm. ... AdSense and AutoLink products do not infringe on ... its subsidiary, HyperPhrase, Inc. The patents, which pertain to a ...
Cached Biology Technology:Flying to the moon? Take Wisconsin tech along 2Flying to the moon? Take Wisconsin tech along 3Flying to the moon? Take Wisconsin tech along 4Damn the incumbents, and full speed ahead 2Damn the incumbents, and full speed ahead 3Damn the incumbents, and full speed ahead 4Wisconsin judge dismisses patent suit vs. Google 2
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/14/2015)... 2015  HYPR Corp. today announced it has ... Alliance tm , an industry consortium transforming online ... share technology and collaborate to deliver open specifications ... secure and private, and easier to use. ... protects sensitive user information and eliminates the dependency ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... just a finger prick away thanks to a new credit ... and Northeastern universities in Boston. In a research report published ... they describe how this device can measure and collect a ... progenitor cells, using only 200 microliters of blood. The development ...
... 1, 2009 REGiMMUNE Corporation today announced that its ... of Sirolimus, demonstrated enhanced efficacy in transplantation tolerance induction ... (GvHD). This data is being presented today in ... Formulation of KRN7000 (RGI-2001) Alone and in Combination with ...
... different species are likely to respond to climate change. ... species and the interactions between species, in the interest ... BioScience , by Eric Post of Pennsylvania State ... be avoided. Their approach, which relies on multi-stage analyses ...
Cached Biology News:New device detects heart disease using less than one drop of blood 2REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 2
Request Info...
Penicillin-Streptomycin liquid...
...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Biology Products: